文献速递前列腺癌

初始主动监测后延迟根治性前列腺切除术对复发结局的影响:来自大型机构队列的结果

The Impact of Delayed Radical Prostatectomy on Recurrence Outcomes After Initial Active Surveillance: Results from a Large Institutional Cohort.
PubMed 文献 · Eur Urol Oncol · 2023-12-05

该研究纳入2000至2020年诊断的1259例cT1-2N0/xM0/x、PSA<20 ng/ml、GG 1-2前列腺癌患者,比较GG 2立即行根治性前列腺切除术与主动监测后升级至GG 2再延迟手术的复发结局。多变量分析显示,阳性活检核心百分比和术前PSA与复发风险显著相关,而手术时机与复发风险无显著差异;作者认为结果支持对部分GG 2患者主动监测及延迟根治性治疗的安全性。

要点

  • 多变量分析中,立即手术与主动监测后延迟手术的复发-free生存无显著差异。
  • 阳性活检核心百分比每增加10%,复发风险HR为1.08(95%CI 1.02-1.15;p=0.01)。
  • 术前PSA与复发风险相关,HR为1.06(95%CI 1.03-1.09;p<0.01)。

核心结论

  • 多变量分析显示,阳性活检核心百分比和术前PSA与根治性前列腺切除术后前列腺癌复发风险相关,而升级至GG 2后根治性手术的时机与复发风险无显著差异。
  • 作者认为这些发现支持对部分GG 2患者主动监测及延迟根治性治疗的安全性。

研究设计与样本

  • 研究为机构队列研究,纳入2000至2020年诊断的cT1-2N0/xM0/x、PSA<20 ng/ml、GG 1-2前列腺癌患者。
  • 1259例符合纳入标准的男性中,979例在诊断GG 2后立即行根治性前列腺切除术,190例在主动监测升级至GG 2后12个月内行根治性前列腺切除术,90例在升级至GG 2后超过12个月行根治性前列腺切除术。
  • 结局为术后无复发生存,复发定义为生化失败(2次PSA测量≥0.2 ng/ml)或接受第二种治疗。
  • 采用多变量Cox比例风险回归模型计算根治性前列腺切除术时机与复发风险的关联,校正诊断时年龄、阳性活检核心百分比、PSA密度、术前PSA、诊断年份、手术切缘、基因组风险评分和前列腺MRI表现。

主要发现

  • 5年无复发生存率:立即手术组为81%,升级后≤12个月手术组为80%,升级后>12个月手术组为70%(单因素log-rank p=0.03)。
  • Cox多变量回归显示,GG 2立即行根治性前列腺切除术与主动监测升级后延迟行根治性前列腺切除术之间的无复发生存结局无差异。
  • 阳性活检核心百分比每增加10%,复发风险HR为1.08(95%CI 1.02-1.15;p=0.01),与复发风险显著相关。
  • 术前PSA与复发风险显著相关,HR为1.06(95%CI 1.03-1.09;p<0.01)。

临床怎么用

  • 作者认为这些发现支持对部分GG 2患者主动监测及延迟根治性治疗的安全性。
  • 原文未据此给出其他推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Active surveillance (AS) of prostate cancer (PCa) involves regular monitoring for disease progression. The aim is to avoid unnecessary treatment while ensuring appropriate and timely treatment for those whose disease progresses. AS has emerged as the standard of care for low-grade (Gleason grade 1, GG 1) PCa. Opponents are concerned that initial undersampling and delay of definitive management for patients with GG 2 disease may lead to adverse outcomes. We sought to determine whether the timing for definitive management of GG 2 PCa, either upfront or after initial AS, affects recurrence outcomes after radical prostatectomy (RP). METHODS: Participants were diagnosed with cT1-2N0/xM0/x, prostate-specific antigen (PSA) <20 ng/ml, and GG 1-2 PCa between 2000 and 2020 and underwent immediate RP for GG 2 or AS followed by delayed RP on upgrading to GG 2. The outcome was recurrence-free survival (RFS) after surgery, with recurrence defined as either biochemical failure (2 PSA measurements ≥0.2 ng/ml) or a second treatment. Multivariable Cox proportional-hazards regression models were used to calculate associations between the timing for definitive RP and the risk of recurrence, adjusted for age at diagnosis, percentage of positive biopsy cores (PPC), PSA density, PSA before RP, year of diagnosis, surgical margins, genomic risk score, and prostate MRI findings. KEY FINDINGS: Of the 1259 men who met the inclusion criteria, 979 underwent immediate RP after diagnosis of GG 2, 190 underwent RP within 12 mo of upgrading to GG 2 on AS, and 90 men underwent RP >12 mo after upgrading to GG 2. The 5-yr RFS rates were 81% for the immediate RP group, 80% for the delayed RP ≤12 mo, and 70% for the delayed RP >12 mo group (univariate log-rank p = 0.03). Cox multivariable regression demonstrated no difference in RFS outcomes between immediate RP for GG 2 disease and delayed RP after upgrading on AS. PPC (hazard ratio [HR] per 10% increment 1.08, 95% confidence interval [CI] 1.02-1.15; p = 0.01) and PSA before RP (HR 1.06, 95% CI 1.03-1.09; p < 0.01) were significantly associated with the risk of recurrence. CONCLUSIONS AND CLINICAL IMPLICATIONS: PPC and PSA before RP, but not the timing of definitive surgery after upgrade to GG 2, were associated with the risk of PCa recurrence after RP on multivariable analysis. These findings support the safety of AS and delayed definitive therapy for a subset of patients with GG 2 disease. PATIENT SUMMARY: In a large group of 1259 patients with low-grade prostate cancer, we found that delaying surgical treatment after an initial period of active surveillance resulted in no differences in prostate cancer recurrence. Our results support the safety of active surveillance for low-grade prostate cancer.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Shee K, Cowan JE, Washington SL, et al. The Impact of Delayed Radical Prostatectomy on Recurrence Outcomes After Initial Active Surveillance: Results from a Large Institutional Cohort. Eur Urol Oncol. 2023. PMID: 38057193. doi:10.1016/j.euo.2023.11.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。